C
CardioLogs
Democratizes expert cardiac care globally, by empowering all actors in the care chain with AI
About CardioLogs
Cardiologs is a pioneering company in the field of medical-grade artificial intelligence (AI) focused on transforming the way cardiovascular diseases are diagnosed and managed. The company operates in the digital health market, providing an AI-powered platform that offers accurate and automated analysis of electrocardiograms (ECGs). Cardiologs serves healthcare professionals, including physicians and clinicians, by providing them with intelligent tools to enhance their diagnostic capabilities. The platform is clinically validated and can detect more than 20 types of arrhythmia events, significantly improving the specificity and sensitivity of diagnoses. Cardiologs generates revenue through a subscription-based business model, offering its platform to healthcare institutions and professionals on a recurring basis. By streamlining operational workflows and providing clinical accuracy, Cardiologs aims to empower clinicians and improve patient care globally.
Source: Dealroom company dataAt a glance
- Status
- Closed
- Founded
- 2014
- Headquarters
- Paris, France
- Employees
- 64
- Open positions
- 6
- Dealroom signal
- 0.0/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Analytics, Cardiology and cardiovascular, Remote Monitoring, Medical Imaging, Core AI, Health Diagnostics, Tech for Hospitals and Clinics
- Technology
- Artificial Intelligence, Deep Tech, Deep Learning
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Nov 2021 | $0 | — | Philips | — |
| SERIES A✓Equity / VC | Jan 2020 | $15M | $60M | Kurma Partners · ISAI Gestion · Partech · Eurazeo | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for CardioLogs is 15K monthly website visits, up 80.7% over the last three months. CardioLogs's team declined 22% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Other known investors10 additional known investors
Philips
Agoranov
jean-patrice anciaux- JUJonathan Userovici
MH Innov'
Orange Fab
Paris Saclay Seed Fund
Reza Malekzadeh- SLSacha Loiseau
StartX
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about CardioLogs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CardioLogs’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.